Innovation

We have been in the process of investigating novel therapies, identifying innovative applications for technology in medicine and developing emerging biomedical technologies.

These efforts exist in collaboration with the UCLA Center for SMART Health, UCLA School of Bioengineering, UCLA Center for Inflammatory Bowel Diseases(Link opens in new window) and several external academic and industry partners. Applications under development include novel drug candidates, mobile technologies and artificial intelligence for gastroenterology and nutrition.

Related publications

• Limketkai BN, Li Z, Mullin GE, Parian AM. Machine learning-based prediction of mortality among malnourished patients hospitalized with inflammatory bowel disease(Link is external). J Clin Gastroenterol. 2025 Jan 20
• Kim S, Zhang Y, Mauldin K & Limketkai BN. Advances in digital health for gastrointestinal nutrition(Link is external). Current Treatment Options in Gastroenterology. 03 August 2024
• Limketkai BN, Maas L, Krishna M, Dua A, DeDecker L, Sauk JS, Parian AM. Machine learning-based characterization of longitudinal health care utilization among patients with inflammatory bowel diseases(Link is external). Inflammatory Bowel Diseases, izad127, July 15, 2023
• Spartz EJ, DeDecker L, Le D, Jalilian L, Limketkai BN. Advances in mobile health for inflammatory bowel disease(Link is external). Diagnostics (Basel). 2022 Dec 23;13(1):37
• Limketkai BN, Mauldin K, Manitius N, Jalilian L, Salonen BR. The age of artificial intelligence: Use of digital technology in clinical nutrition(Link is external) (Link opens in new window). Current Surgery Reports. 2021;9(7) 20
• Saiki JP, Andreasson JO, Grimes KV, Frumkin LR, Sanjines E, Davidson MG, Park KT, Limketkai B. Treatment-refractory ulcerative colitis responsive to indigo naturalis(Link is external) (Link opens in new window). BMJ Open Gastroenterol 2021;8(1)